Chong Kun Dang Receives Order to Suspend Manufacturing and Sales of 9 Pharmaceuticals
[Asia Economy Reporter Baek Kyunghwan] Chong Kun Dang announced on the 21st that it received a provisional manufacturing and sales suspension order from the Daejeon Regional Food and Drug Administration for nine pharmaceuticals, including Lipiro 10mg tablets. The company stated, "This order is a provisional manufacturing and sales suspension order," and explained, "If we receive a confirmed order regarding the suspension period in the future, we will immediately disclose it or re-disclose it within one month."
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
